Related Experiment Video
Updated: Mar 2, 2026

06:39
Culture of myeloid dendritic cells from bone marrow precursors
Published on: July 25, 2008
23.2K
Platelet concentrates modulate myeloid dendritic cell immune responses
Katrina K Ki1,2, Helen M Faddy1,2, Robert L Flower1
1a Research and Development , The Australian Red Cross Blood Service , Brisbane , QLD , Australia.
Platelets
|May 16, 2017
Summary
Platelet concentrates (PC) can suppress immune cells like myeloid dendritic cells (mDCs) and BDCA3+ DCs, especially during infection. This immune modulation by PC may explain poor patient outcomes in transfused individuals, particularly those with infections.
Area of Science:
- Immunology
- Transfusion Medicine
- Cellular Biology
Background:
- Platelet transfusion is known to affect the recipient's immune system, but the mechanisms behind adverse outcomes like increased mortality and infection are unclear.
- Dendritic cells (DCs), crucial immune regulators, play a key role in initiating adaptive immune responses.
- Understanding how platelet concentrates (PC) impact DC function is vital for improving transfusion safety and patient care.
Purpose of the Study:
- To investigate the immunomodulatory effects of platelet concentrates (PC) on human myeloid dendritic cells (mDCs) and blood DC antigen (BDCA)3+ DCs in vitro.
- To assess the impact of PC on DC maturation, activation, and cytokine production, particularly in the context of simulated viral and bacterial infections.
- To explore the potential link between PC-induced DC modulation and adverse patient outcomes following transfusion.
Main Methods:
- Establishment of a human whole blood in vitro model to simulate platelet transfusion.
- Exposure of mDCs and BDCA3+ DCs to fresh (D2) and expired (D5) buffy-coat derived PC.
- Addition of polyinosinic:polycytidylic acid (viral infection model) or lipopolysaccharide (bacterial infection model) to assess DC responses under infectious conditions.
- Analysis of DC surface marker expression (e.g., CD40, CD80, CD83, CD86) and quantification of inflammatory cytokine production (e.g., IL-8, IL-12, TNF-α, IL-6, IP-10).
Main Results:
- Platelet concentrates (PC) significantly modulated BDCA3+ DCs more than mDCs, downregulating co-stimulatory molecules (CD40, CD80) and maturation markers (CD83).
- PC suppressed the production of key inflammatory cytokines, including IL-8, IL-12, TNF-α, and IL-6, by both mDCs and BDCA3+ DCs, with effects varying between fresh and expired PC and infection models.
- In simulated viral and bacterial infections, PC exposure further altered DC cytokine profiles, reducing immune mediators essential for effective pathogen clearance.
Conclusions:
- Platelet concentrate transfusion modulates the maturation and activation of myeloid dendritic cells (mDCs) and BDCA3+ DCs.
- PC-induced suppression of DC function and inflammatory cytokine production may impair the recipient's immune response, particularly during infection.
- These findings suggest a potential mechanism by which platelet transfusion, especially in infected patients, could contribute to poor clinical outcomes.

